Clinical Trial Update: Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial (IHELP) evaluated infliximab in psoriasis patients categorized as high need versus low need; the study completed and results were posted in 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Infliximab (Remicade) (Infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-07-05